Cardiff Oncology To Present Posters At American Association For Cancer Research Apr. 11-12, 2022
Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced the publication of two abstracts that have
Cardiff Oncology: Q4 Earnings Insights
Cardiff Oncology (NASDAQ:CRDF) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:10 PM.
Here's what investors need to know about the announcement.
38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 29.8% to $0.2550. Baudax Bio, last month, announced a $4.2 million registered direct offering.